Dual-energy X-ray absorptiometry and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis using data from the Australian Rheumatology Association Database

Written By Lucia Marcello

Andrea Lyon, Susan Lester, Jessica Stanhope, Tom Lynch, Rachel Black, Claire Barrett, Marissa Lassere, Rachelle Buchbinder, Lyn March, Oscar Russell & Catherine Hill.

Dual-energy X-ray absorptiometry and anti-osteoporotic medication use in Australian patients with early rheumatoid arthritis using data from the Australian Rheumatology Association Database. Intern Med J. 2025 Apr 15. doi: https://doi.org/10.1111/imj.70065

Lucia Marcello
Previous

Supporting wellness after cancer treatment for women from Chinese, Vietnamese, and Arabic backgrounds: a qualitative study of healthcare provider views
Next

Radiation oncology patients’ perceptions of artificial intelligence and machine learning in cancer care: A multi-centre cross-sectional study